CSRXP: BIG PHARMA’S EGREGIOUS PRICING OF UNPROVEN ALZHEIMER’S TREATMENT DRIVES HIGHER PREMIUMS FOR SENIORS

11-12-2021 Press Release

Biogen’s Staggering $56,000 Price Tag for Treatment With No Proven Clinical Benefit Will Cost Medicare Part B Outpatients $21.60 More Per Month For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today on news that Medicare Part B premiums for outpatient beneficiaries will increase by […]

CSRXP APPLAUDS INCLUSION OF PRESCRIPTION DRUG PRICING SOLUTIONS IN LATEST FRAMEWORK

11-2-2021 Press Release

Congress Should Reject Pharma-backed Proposals That Would Hike Health Care Premiums, Advance Solutions to Deliver Real Rx Relief for the American People For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Tuesday reacting to the release of a drug pricing compromise package to be included […]

CSRXP: WHITE HOUSE FRAMEWORK FAILS ON PROMISE TO LOWER DRUG PRICES

10-28-2021 Press Release

Framework Fails to Hold Big Pharma Accountable and Lower Drug Prices for the American People For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today in response to the release of a framework from President Biden for the Build Back Better Act. “This framework fails […]

CSRXP WELCOMES FDA APPROVAL OF FIRST INTERCHANGEABLE BIOSIMILAR FOR HUMIRA AS POSITIVE FIRST STEP

10-20-2021 Press Release

U.S. Food & Drug Administration Approval of Cyltezo Marks Second Interchangeable Biosimilar Approved by Agency For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today in response to the Food and Drug Administration’s (FDA) decision Monday to approve interchangeable biosimilar Cyltezo, as an alternative to […]

CSRXP ENCOURAGES HOUSE JUDICIARY COMMITTEE TO CRACK DOWN ON BIG PHARMA’S PATENT ABUSE

09-29-2021 Press Release

Committee Mark Up Targets Brand Name Drug Companies’ Anti-Competitive Tactics That Undermine More Affordable Alternatives For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today in advance of a U.S. House of Representatives Committee on the Judiciary mark up of two bills that […]

CSRXP POLL: MASSIVE MAJORITIES OF AMERICAN VOTERS SUPPORT SOLUTIONS TO LOWER DRUG PRICES AND HOLD BIG PHARMA ACCOUNTABLE

09-14-2021 Press Release

Americans Blame Big Pharma for Out-of-Control Drug Prices, Reject Bogus Innovation Rhetoric And Say Lack of Action in Congress Would Impact Vote in Next Election For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released the results of a national survey conducted by Morning Consult Tuesday. “The […]

CSRXP: HOUSE MARKUPS ADD TO UNPRECEDENTED MOMENTUM TO HOLD BIG PHARMA ACCOUNTABLE

09-14-2021 Press Release

Committee Leaders Put Forward Solutions to Lower Prescription Drug Prices for Patients, Seniors and Taxpayers Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Tuesday on the start of legislative markups before the U.S. House Committee on Energy & Commerce and Committee on Ways & Means on policies to address out-of-control prescription drug prices. […]

CSRXP APPLAUDS RELEASE OF HHS PLAN TO LOWER PRESCRIPTION DRUG PRICES AND HOLD BIG PHARMA ACCOUNTABLE

09-9-2021 Press Release

Administration Proposal Would Increase Competition, Transparency and Value — Reform Medicare Part D to Protect Seniors and Taxpayers Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Thursday in response to the release of a comprehensive plan to lower prescription drug prices from U.S. Department of Health & Human Services (HHS) Secretary Xavier […]

CSRXP APPLAUDS PRESIDENT BIDEN’S COMMITMENT TO LOWERING PRESCRIPTION DRUG PRICES AND CALL FOR CONGRESS TO ACT

08-12-2021 Press Release

Speech Adds to Unprecedented Momentum for Action, Now Lawmakers Must Deliver on Repeated Promises to Hold Big Pharma Accountable For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Thursday reacting to a landmark speech from President Biden calling on Congress to pass solutions to lower […]

CSRXP STATEMENT ON U.S. SENATE PASSAGE OF REBATE RULE DELAY & REFUND ACT AS PART OF BIPARTISAN INFRASTRUCTURE BILL

08-10-2021 Press Release

Lawmakers Must Build on Momentum For Action With Permanent Repeal of Rebate Rule and Solutions to Hold Big Pharma Accountable and Lower Drug Prices For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Tuesday reacting to the U.S. Senate passage of the bipartisan […]

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.